Clinical Trial Update: A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

View source ↗

Summary

This clinical trial update describes a study evaluating the effectiveness of cabozantinib in combination with nivolumab as first-line treatment for adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Cotellic (cobimetinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: Ipsen | Conditions: Advanced Renal Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING